Mesoblast Limited Share Price
Stocks
MSB
AU000000MSB8
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.975 AUD | +1.28% |
|
-1.74% | -27.39% |
| 12/06 | Mesoblast Says JPMorgan Ceases to be Substantial Holder | MT |
| 30/04 | Mesoblast Says Nearly $100 Million in Revenue Generated During First Year of Ryoncil Launch; Shares Fall 5% | MT |
| Market Cap | 252.7Cr 178.75Cr 154.04Cr 141.85Cr 133.18Cr 250.06Cr 17TCr 1.68TCr 653Cr 8.28TCr 670.82Cr 656.58Cr 29TCr | P/E 2026 * |
-29.9x | P/E 2027 * | 72.3x |
|---|---|---|---|---|---|
| Enterprise Value | 250.85Cr 177.44Cr 152.92Cr 140.82Cr 132.21Cr 248.23Cr 17TCr 1.66TCr 648.24Cr 8.22TCr 665.93Cr 651.79Cr 28TCr | EV / Sales 2026 * |
14.2x | EV / Sales 2027 * | 7.9x |
| Free-Float |
63.83% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Mesoblast Limited
| 1 day | +1.28% | ||
| 1 week | -1.74% | ||
| Current month | -7.71% | ||
| 1 month | -3.19% | ||
| 3 months | -2.23% | ||
| 6 months | -29.46% | ||
| Current year | -27.39% |
| 1 week | 1.92 |  | 2 |
| 1 month | 1.92 | | 2.17 |
| Current year | 1.92 | | 3.31 |
| 1 year | 1.53 | | 3.31 |
| 3 years | 0.26 | | 3.37 |
| 5 years | 0.26 | | 3.37 |
| 10 years | 0.26 | | 5.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Silviu Itescu
CEO | Chief Executive Officer | 69 | 23/03/2011 |
James O'Brien
DFI | Director of Finance/CFO | 59 | 17/11/2025 |
Teresa Montagut
CTO | Chief Tech/Sci/R&D Officer | - | 11/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Silviu Itescu
BRD | Director/Board Member | 69 | 01/01/2007 |
Eric Rose
BRD | Director/Board Member | 75 | 15/04/2013 |
William Burns
BRD | Director/Board Member | 78 | 06/03/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/04 | Buy | Director | 48,86,890 | 0.3787% | ||
| 16/04 | Buy | Director | 23,24,072 | 0.1801% | ||
| 16/04 | Buy | Director | 7,00,000 | 0.0543% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.28% | -1.74% | +8.22% | +68.09% | 178.75Cr | |
| -0.82% | -1.42% | -12.13% | -10.40% | 4.35TCr | |
| +1.28% | +4.70% | +293.71% | +535.99% | 3.33TCr | |
| -0.99% | -1.58% | -0.19% | +31.82% | 2.93TCr | |
| -2.60% | -3.80% | +12.51% | -17.06% | 2.99TCr | |
| -0.29% | +2.65% | +13.24% | +21.04% | 2.54TCr | |
| +1.78% | +8.43% | - | - | 1.44TCr | |
| -1.12% | -1.11% | +53.37% | +108.10% | 1.32TCr | |
| -1.31% | -5.38% | +2.08% | +3.17% | 1.27TCr | |
| +0.27% | -2.00% | +107.41% | +78.18% | 1.21TCr | |
| Average | -0.37% | +0.09% | +53.13% | +90.99% | 2.16TCr | |
| Weighted average by Cap. | -0.60% | +0.59% | +59.62% | +103.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18Cr 13Cr 11Cr 9.94Cr 9.34Cr 18Cr 1.18TCr 117.49Cr 46Cr 580.11Cr 47Cr 46Cr 2.01TCr | 31Cr 22Cr 19Cr 17Cr 16Cr 30Cr 2.05TCr 203.58Cr 79Cr 1.01TCr 81Cr 80Cr 3.48TCr |
| Net income | -7.77Cr -5.49Cr -4.73Cr -4.36Cr -4.09Cr -7.68Cr -519.34Cr -52Cr -20Cr -254.32Cr -21Cr -20Cr -881.36Cr | 3.18Cr 2.25Cr 1.94Cr 1.78Cr 1.67Cr 3.14Cr 212.44Cr 21Cr 8.21Cr 104.03Cr 8.43Cr 8.25Cr 360.53Cr |
| Net Debt | -1.84Cr -1.3Cr -1.12Cr -1.03Cr -97.08L -1.82Cr -123.18Cr -12Cr -4.76Cr -60Cr -4.89Cr -4.79Cr -209.05Cr | -10Cr -7.35Cr -6.33Cr -5.83Cr -5.47Cr -10Cr -694.52Cr -69Cr -27Cr -340.11Cr -28Cr -27Cr -1.18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | 1.975 $ | +1.28% | 17,71,346 |
| 16/26/16 | 1.950 $ | -0.26% | 22,70,662 |
| 15/26/15 | 1.955 $ | +0.26% | 24,18,651 |
| 12/26/12 | 1.950 $ | -1.02% | 21,73,835 |
| 11/26/11 | 1.970 $ | -1.99% | 33,66,553 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MSB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition